Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin in Chinese Patients With Diabetic Peripheral Neuropathic Pain
NCT04094662Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2019
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirogabalin in diabetic polyneuropathy (DPN), sponsored by Daiichi Sankyo Co., Ltd.. Started Sep 2019; status: completed.
02
Drugs
mirogabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT04094662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04094662.